News
Poxel Reports Financial Results for First Half 2022 and Provides a Corporate Update
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone
POXEL SA (Euronext : POXEL - FR0012432516), clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
EQS-News: Defence Therapeutics Inc.: BREAKTHROUGH RESULTS WITH ACCUM(TM) A1-REPROGRAMMED MSC, MESENCHYMAL STEM CELLS, IN A NOVEL VACCINE CURED 80% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA
Press release: KPN announces results of its Tender Offer
EQS-Adhoc: Agreement on Amended Stabilization Package for Uniper
Xlife Sciences strengthens sustainability activities with ESG strategy
EQS-News: Northern Data Becomes Preferred Cloud Service Provider in NVIDIA Partner Network
NGL Water Solutions Featured on Discovery Channel
Advances being made by NGL Energy Partners LP’s (“NGL” or “Partnership”) Water Solutions segment (“NGL Water Solutions”) in sustainable produced water reuse technology and practices were featured
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, today announced an agreement with Takeda to license the worldwide research and development and commercial rights to alisertib
Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology (ACR) Convergence 2022
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today
Schlumberger and Aramco to Collaborate on Digital Sustainability Solutions for Hard-to-Abate Carbon Industries
Schlumberger and Aramco have announced plans to collaborate and develop a digital platform that will provide sustainability solutions for hard-to-abate industrial sectors.
The proposed platform
Columbia Care Inc. Announces Voting Results of Annual General Meeting
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today that, at the annual general meeting (the “Meeting”) of shareholders of the
Verisign Reports Internet Has 351.5 Million Domain Name Registrations at the End of the Second Quarter of 2022
VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that the second quarter of 2022 closed with 351.5 million domain name
Keeping Lone-Star Travelers Moving: Granite Secures Highway Work in Texas
Granite (NYSE:GVA) announced today that is has been awarded two construction contracts worth approximately $107 million on State Highway 288 near Houston, Texas. When combined with the previously
First Internet Bancorp to Pay Cash Dividend
The Board of Directors of First Internet Bancorp (the “Company”) (Nasdaq: INBK) has declared a quarterly cash dividend of $0.06 per common share. The dividend will be payable on October 17, 2022 to
EQS-News: artnet AG: Weng Fine Art AG announces voluntary public acquisition offer to the shareholders of artnet AG
Schlumberger Announces Senior Notes Redemption
Schlumberger Limited (“Schlumberger”) today announced that its subsidiaries will redeem approximately $895 million of senior notes due 2022.
Schlumberger Finance Canada Ltd., an indirect wholly
Affluent Medical : Success of the capital increase with preferential subscription rights for a gross amount of €6 million.
EQS-News: Burcon NutraScience Corp.: Burcon Announces Breakthrough in Sunflower Protein Development
